2017
DOI: 10.1093/rheumatology/kex162
|View full text |Cite
|
Sign up to set email alerts
|

Environmental factors associated with disease flare in juvenile and adult dermatomyositis

Abstract: Certain classes of environmental agents that have been associated with the initiation of DM, including sun exposure and medications, may also play a role in disease flares.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
22
0
5

Year Published

2018
2018
2022
2022

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 52 publications
(27 citation statements)
references
References 15 publications
0
22
0
5
Order By: Relevance
“…Photosensitivity is reported in nearly half of patients with juvenile myositis (JM) , and exacerbations of skin disease following sun exposure have been described. Once DM is established, UV radiation appears to be a strong trigger: laboratory testing of non‐irradiated skin of adults with DM determined increased sensitivity to ultraviolet B (UVB) radiation compared to healthy controls, many of whom also reported photosensitivity and disease exacerbation following sun exposure , and questionnaire data from patients with DM and JM suggested that UV exposure is an important environmental exposure correlated with disease flares .
This study explores the association between the environmental factor ultraviolet (UV) radiation and disease severity outcomes in a large registry of patients with juvenile dermatomyositis (DM) by integrating clinical and demographic data from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry with historical National Aeronautics and Space Administration satellite measurements. Mean UV index (UVI) exposure in the month prior to disease onset was associated with development of calcinosis; however, the directionality of this relationship was dependent on race. Mean UVI exposure was not associated with other features representative of severe disease, including skin ulceration, a Childhood Health Assessment Questionnaire score >1, use of biologics or nonmethotrexate disease‐modifying antirheumatic drugs, use of intravenous immunoglobulin, or persistent skin disease, muscle weakness, or steroid use beyond 2 years of disease duration. These results further our knowledge of the role of UV radiation in the clinical course of juvenile DM and highlight the need for clinicians and researchers to be aware of the complex interplay of genes and environment in the clinical phenotypes of children with juvenile DM.
…”
Section: Introductionmentioning
confidence: 99%
“…Photosensitivity is reported in nearly half of patients with juvenile myositis (JM) , and exacerbations of skin disease following sun exposure have been described. Once DM is established, UV radiation appears to be a strong trigger: laboratory testing of non‐irradiated skin of adults with DM determined increased sensitivity to ultraviolet B (UVB) radiation compared to healthy controls, many of whom also reported photosensitivity and disease exacerbation following sun exposure , and questionnaire data from patients with DM and JM suggested that UV exposure is an important environmental exposure correlated with disease flares .
This study explores the association between the environmental factor ultraviolet (UV) radiation and disease severity outcomes in a large registry of patients with juvenile dermatomyositis (DM) by integrating clinical and demographic data from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry with historical National Aeronautics and Space Administration satellite measurements. Mean UV index (UVI) exposure in the month prior to disease onset was associated with development of calcinosis; however, the directionality of this relationship was dependent on race. Mean UVI exposure was not associated with other features representative of severe disease, including skin ulceration, a Childhood Health Assessment Questionnaire score >1, use of biologics or nonmethotrexate disease‐modifying antirheumatic drugs, use of intravenous immunoglobulin, or persistent skin disease, muscle weakness, or steroid use beyond 2 years of disease duration. These results further our knowledge of the role of UV radiation in the clinical course of juvenile DM and highlight the need for clinicians and researchers to be aware of the complex interplay of genes and environment in the clinical phenotypes of children with juvenile DM.
…”
Section: Introductionmentioning
confidence: 99%
“…3 The predisposition for JDM may be flared by environmental factors such as sun exposure, medications, or certain infections. 4 Suspected organisms inciting JDM are group A beta hemolytic streptococci, 5 enterovirus, 2 and Coxsackie B virus. 6 The third may serve a clue as to why there seems to be a seasonal nature to the disease with a higher incidence occurring in nonwinter months.…”
Section: Juvenile Dermatomyositismentioning
confidence: 99%
“…In this sense, several immunogenetic risk factors, including certain class-2 human leukocyte antigen (HLA) alleles, have been implicated in dermatomyositis pathogenesis [23]. Studies suggest that exposure to ultraviolet light may also be considered an important risk factor for the development of dermatomyositis [24].…”
Section: Dermatomyositismentioning
confidence: 99%
“…Histopathological hallmarks of polymyositis include invasion of endomysial cytotoxic CD8 T cells and widespread upregulation of class I MHC in muscle fibers [2,24]. Polymyositis is a chronic, degenerative disease that has no cure.…”
Section: Polymyositismentioning
confidence: 99%